BPC-157 peptide can be used to promote the healing of muscles, tendons, ligaments, and the gut lining, while also supporting hormone balance
Some use 30 days
Vial Size by Protocol Tolerance testing: A 2mg or 5mg vial is the smallest unit cited 1-3 weeks at standard doses Standard 200mcg/day pre-bedtime protocol: 5mg vial 25 days, fits the stability window The most-cited size in vendor sales data 1-2 vials per month Extended cycles: 10mg 5 kit drops cost to $4.40-10/mg Each vial reconstituted only when needed
No FDA-approved human trial
Retatrutides ~24.2% (48 wk, 12 mg monotherapy) and cagrilintides ~10.8% (26 wk, 4.5 mg monotherapy) differ in duration and dose, and cagrilintides strongest data are combination (CagriSema) data
Scientists isolated and synthesized the active peptide fragment, BPC-157, and discovered that it retained and amplified many of the original compounds healing benefitsextending far beyond the gastrointestinal system